849
Views
10
CrossRef citations to date
0
Altmetric
Review

The molecular basis for current targets of NASH therapies

&
Pages 151-161 | Received 07 Dec 2019, Accepted 08 Dec 2019, Published online: 18 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefano Fiorucci, Michele Biagioli, Valentina Sepe, Angela Zampella & Eleonora Distrutti. (2020) Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH). Expert Opinion on Investigational Drugs 29:6, pages 623-632.
Read now

Articles from other publishers (9)

Jing Tan, Jianhua He, Lijun Wang, Jia Fang, Pengyi Li, Zhenghuan Song & Qingming Bian. (2023) Analysis of the association of sugammadex with the length of hospital stay in patients undergoing abdominal surgery: a retrospective study. BMC Anesthesiology 23:1.
Crossref
He-ming Huang, Shi-jie Fan, Xiao-ru Zhou, Yan-jun Liu, Xiao Li, Li-ping Liao, Jing Huang, Cui-cui Shi, Liang Yu, Rong Fu, Jian-gao Fan, Yuan-yuan Zhang, Cheng Luo & Guang-ming Li. (2021) Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis. Acta Pharmacologica Sinica 43:4, pages 941-953.
Crossref
A. Fabrizzio Bardales Silva. (2022) Enfermedad hepática grasa relacionada a trastornos metabólicos. Revista Médica Basadrina 15:4, pages 85-93.
Crossref
Bing Liu, Wei Yi, Xiaoxiang Mao, Ling Yang & Caijun Rao. (2021) Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis. American Journal of Physiology-Endocrinology and Metabolism 320:5, pages E925-E937.
Crossref
Bingting Yu, Ruslan Mamedov, Gwenny M. Fuhler & Maikel P. Peppelenbosch. (2021) Drug Discovery in Liver Disease Using Kinome Profiling. International Journal of Molecular Sciences 22:5, pages 2623.
Crossref
Christopher R. Shepard. (2021) TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. Frontiers in Endocrinology 11.
Crossref
Metin Basaranoglu & Alev Kurtoglu. (2021) Replacing the Name of NAFLD With a Metabolic or Another Forename as Indicator of the Era of Stagnation in NASH Studies. Journal of Clinical Gastroenterology Publish Ahead of Print.
Crossref
Sarah Altajar & Gyorgy Baffy. (2020) Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 8:4, pages 1-10.
Crossref
Francisco Idalsoaga, Anand V. Kulkarni, Omar Y. Mousa, Marco Arrese & Juan Pablo Arab. (2020) Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Frontiers in Medicine 7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.